SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001593968-18-001081
Filing Date
2018-07-30
Accepted
2018-07-30 17:14:50
Documents
2
Period of Report
2018-07-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 4  
1 PRIMARY DOCUMENT primary_01.xml 4 3841
2 EX-24 DOCUMENT poa_boardman.txt EX-24 4238
  Complete submission text file 0001593968-18-001081.txt   9520
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 212-308-6000
Kadmon Holdings, Inc. (Issuer) CIK: 0001557142 (see all company filings)

IRS No.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KADMON HOLDINGS, LLC 450 E. 29TH STREET NEW YORK NY 10016
Business Address
Boardman D. Dixon (Reporting) CIK: 0001678605 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37841 | Film No.: 18978544